510 related articles for article (PubMed ID: 3404441)
1. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
Kopia GA; Ohlstein EH; Ruffolo RR
J Pharmacol Exp Ther; 1988 Aug; 246(2):434-40. PubMed ID: 3404441
[TBL] [Abstract][Full Text] [Related]
2. Coronary vascular activity of the novel inotropic pro-drug ibopamine and the de-esterified active form epinine.
Ohlstein EH; Kopia GA; Ruffolo RR
Arzneimittelforschung; 1988 Dec; 38(12):1790-2. PubMed ID: 3245851
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
[TBL] [Abstract][Full Text] [Related]
4. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
Merlo L; Ghirardi P; Brusoni B; Mussini E; Marchetti G
Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the alpha adrenoceptor activity of dopamine, ibopamine and epinine in the pulmonary circulation of the dog.
Shebuski RJ; Fujita T; Smith JM; Ruffolo RR
J Pharmacol Exp Ther; 1987 Apr; 241(1):6-12. PubMed ID: 3033210
[TBL] [Abstract][Full Text] [Related]
6. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
Veit S; Brückner JB; Vogt K; Wagner R; Hess W
Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic response to ibopamine in acute myocardial infarction.
Taniguchi H; Iwasaka T; Sugiura T; Takayama Y; Sumimoto T; Onoyama H; Takashima H; Nakamura S; Inada M
Arzneimittelforschung; 1990 Apr; 40(4):428-31. PubMed ID: 2357243
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the cardiohemodynamic effects of ibopamine, an orally-active dopamine analogue, in the anesthetized open-chest guinea pig and the isolated guinea pig atria.
Matsui K; Imai S
Jpn J Pharmacol; 1986 Oct; 42(2):217-27. PubMed ID: 3795623
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
Gavazzi A; Mussini A; Bramucci E
Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
[TBL] [Abstract][Full Text] [Related]
10. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
[TBL] [Abstract][Full Text] [Related]
11. Effects of ibopamine on acute cardiac failure following experimental coronary occlusion in dogs.
Marchetti G; Merlo L
Arzneimittelforschung; 1986 Feb; 36(2A):331-3. PubMed ID: 3707644
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
De Vita C; Triulzi E; Devizzi S; Colombo G; Palvarini M; Pocchiari F; Pataccini R
Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
[TBL] [Abstract][Full Text] [Related]
13. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous epinine administration on left ventricular systolic performance, coronary hemodynamics, and circulating catecholamines in patients with heart failure.
Rousseau MF; Raigoso J; van Eyll C; Van Mechelen H; Musso NR; Lotti G; Pouleur H
J Cardiovasc Pharmacol; 1992 Feb; 19(2):155-62. PubMed ID: 1376782
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine.
Nichols AJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):455-63. PubMed ID: 3039117
[TBL] [Abstract][Full Text] [Related]
16. Effects of magnesium chloride on cardiovascular hemodynamics in the neurally intact dog.
Friedman HS; Nguyen TN; Mokraoui AM; Barbour RL; Murakawa T; Altura BM
J Pharmacol Exp Ther; 1987 Oct; 243(1):126-30. PubMed ID: 3668845
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the positive inotropic effect of ibopamine in the blood-perfused canine papillary muscle.
Kawahara K; Inui J
J Cardiovasc Pharmacol; 1985; 7(2):316-20. PubMed ID: 2581086
[TBL] [Abstract][Full Text] [Related]
18. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
19. Effects of toborinone on myocardial oxygen consumption in pacing-induced heart failure dogs.
Itoh S; Mori T; Fujiki H; Tominaga M
Arzneimittelforschung; 1996 Dec; 46(12):1105-9. PubMed ID: 9006782
[TBL] [Abstract][Full Text] [Related]
20. [Ornipressin (POR 8)--effect on coronary blood circulation and the peripheral circulation. An animal experimental study].
Veit S; Poethko C; Heidelmeyer CF; Brückner JB
Anaesthesist; 1993 Sep; 42(9):597-604. PubMed ID: 8214531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
